The purpose of this study was to evaluate the ability of men who have sex with men (MSM) testing for HIV at commercial sex venues to assess the following: their candidacy for pre-exposure chemoprophylaxis (PrEP) as defined by meeting entry criteria for the iPrEx (Iniciativa Profilaxis Pre-Exposición) phase III clinical trial of PrEP, and their perception of their own HIV risk and candidacy for PrEP. Interviewers surveyed 629 MSM at three NYC commercial sex venues from June 2011 through June 2012. Questions focused on demographics, sexual activity, and drug use in the three months prior to testing, as well as perceived risk of HIV acquisition and perceived candidacy for PrEP use. Data were analyzed by Chi square and Fisher's exact test. Results show that a majority of clients (80.3%) met entry criteria for the iPrEX. Most of these men (78.0%), however, did not perceive their risk to be significant enough to warrant PrEP use (P = .000). Factors were identified which associated with a risk perception that correlated with eligibility for iPrEX.
Introduction
G ay, bisexual, and other men who have sex with other men (MSM) represent an estimated 2-5% of the US population, but are disproportionately affected by HIV. Unprotected sex between men continues to drive the domestic epidemic, with 53% of new HIV diagnoses in the US attributed to this behavior in 2007 and 65% of incident infections in 2011. 1, 2, 3 In New York City, the Department of Health and Mental Hygiene recorded 3,404 new HIV diagnoses in 2011, of which 1,749 (51.4%) were MSM. 4 Many of these men at risk for HIV continue to under-utilize preventive services such as testing and post-exposure prophylaxis. 5 Knowledge of HIV status has important effects on behavior and health. In this sense, testing can be considered a preventive measure. However, the CDC estimates that over 20% of HIV positive MSM are unaware of their status. 6, 7, 8, 9 Self-perception of risk for acquiring a disease has been shown to be an important motivating factor leading individuals to seek diagnostic testing and other preventive services. 10, 11, 12, 13, 14 In the case of MSM, a lack of self-awareness of risk may result in missed opportunities to prevent HIV. 15, 16 Compounding this lack of self-awareness of risk is the limited disclosure of sexual behavior by MSM to healthcare providers.
5,17
Iniciativa Profilaxis Pre-Exposición (iPrEX) was an international, randomized, placebo-controlled study that showed the efficacy of daily pre-exposure administration of a fixed dose of tenofovir and emtricitabine in reducing the incidence of HIV infection in sexually-active MSM participants by 44%. Eligibility for inclusion in the iPrEX trial was determined by meeting at least one objective measure correlated with high-risk sexual exposure as detailed below. Significantly higher rates of protection were noted in men in the treatment arm who adhered fully to their assigned study drug regimen, as evidenced by detectable levels in their plasma and cells. 18 Despite these findings, knowledge and use of pre-exposure prophylaxis (PrEP) remains low, even among sexually active MSM. 5, 19, 20 The successful implementation of PrEP as a part of combined-modality preventive services requires both the identification of individuals at risk for HIV infection, through self-identification or through identification by a healthcare worker, and the subsequent linkage of these individuals to appropriate resources. Many barriers exist to identifying such individuals at-risk. We hypothesized one significant barrier is the lack of self-recognition of personal risk that may warrant the use of pre-exposure prophylaxis to prevent acquisition of HIV.
In this observational study, we examined the behaviors reported by a population of MSM presenting for HIV testing at commercial sex venues in New York City. In the absence of consensus criteria to assess risk behaviors and candidacy for PrEP, we used iPrEX eligibility criteria as an objective measure of whether or not personal risk is high enough to warrant PrEP use. Thus, using iPrEX study entry criteria, we dichotomized this population into two groups based on reported behavior: those who met iPrEX entry criteria, and those who did not. We then examined how personal perception of PrEP candidacy, based on engagement in sexual activities, compared to iPrEX grouping and what demographic and behavioral factors were associated with discordance between self-perception and iPrEX-based criteria for PrEP candidacy.
Methods
The Men's Sexual Health Project (M*SHP) is an HIV and sexually transmitted infections (STI) testing program targeting MSM, attending three commercial sex venues (CSV) in New York City. The sites include two bathhouses and one sex club. After providing informed consent by signing an NYU School of Medicine Institutional Review Board (IRB)-approved consent form, subjects completed a previously described staffadministered questionnaire that included questions focusing on demographics, sexual activity, and drug use in the three months prior to testing. 21 Subjects for this study were recruited between June 2011 and June 2012.
Based on this data collection, participants were categorized into two groups: ''iPrEX candidates'' and ''noniPrEX candidates'' to reflect whether their behaviors would have qualified them for inclusion into iPrEX based on a high level of risk. To qualify for iPrEX, MSM had to have reported at least one of the following: anal sex with three or more male partners, transactional sexual activity, condomless anal sex with a partner who is HIV positive or of unknown HIV status, or having been diagnosed with a sexually transmitted infection in the last six months.
Participants were read a definition of PrEP that stated: ''Recent studies have shown that HIV medications may be used by men at risk for HIV infection to prevent getting infected.'' Participants were subsequently asked if they felt that the behaviors they reported were risky enough to merit the use of PrEP.
Analysis
Chi square and Fisher's exact test were used to examine factors associated with group membership (meeting vs. not meeting iPrEX eligibility criteria) and perception of HIV risk and PrEP eligibility. Chi square tests were used when values in tables were too small to allow for calculation of a Fisher's exact test.
Results
A group of 629 men who demonstrated a high frequency of sexual activity and concomitant recreational drug use participated in this study. Study participants were all MSM with 75.3% identifying as gay and 15.4% identifying as bisexual or queer. The age range of participants was 17 to 81 years old, and the median age of participants was 32.0 years old; 47.8% were non-white, and 76.8% identified their education level as Bachelor's degree or higher. Concerning current medical care, 64.4% of responders had a primary care physician (PCP) and 69.7% of these individuals stated that their PCP was aware of their MSM status. Alcohol, marijuana, and amyl nitrites (poppers) were widely used (46.2%, 33.3%, and 37.4% respectively) in the sample. The median number of sexual partners reported in the previous 90 days, including oral, anal, and vaginal sex, was 5 with an Interquartile Range of 2-10. Most participants, 90.9%, reported oral sex in the previous 90 days, 73.5% anal insertive sex, and 55.4% anal receptive sex (See Table 1 ).
Comparison of iPrEX Candidacy and Self-Perceived Risk-Based Qualification for PrEP
Most clients (505 individuals, 80.3%) reported behaviors that would have qualified them for participation in the iPrEx study. Of these men, 469 completed questions about selfperception of PrEP candidacy, 366 (78.0%) of these men who completed the survey did not perceive their risk to be significant enough to warrant PrEP (P = .000). A minority of clients identified their behaviors as risky enough to warrant PrEP use with 93.6% of this group meeting criteria for iPrEX entry. No demographic factors predicted congruence between selfperception of meeting iPrEX criteria and meeting or not meeting those criteria. Having a PCP, even if that physician knew the patient's MSM status, did not confer a more accurate perception of potential PrEP candidacy (P = .716 and P = .838). The use of certain illicit drugs (Crystal Meth, GHB, and Ketamine) was correlated with correctly identifying risk (P = .001, P = .007, and P = .018, respectively), as was the use of erectile dysfunction medication (P = .000). Various sexual habits were also associated with correctly identifying potential PrEP candidacy. Clients who reported that more than half of their oral sexual experiences were with strangers assessed their candidacy more accurately (P =.002). Additionally, clients who engaged in unprotected anal sex, either insertive or receptive, were more likely to identify their behaviors as risky enough to merit PrEP (P = .002, and P = .000) (See Tables 2 and 3) .
Discussion
Overall, only 22.0% of subjects who met iPrEX eligibility criteria reported that their self-perceived behavioral risk was high enough to potentially warrant the use of PrEP. As antiretrovirals become increasingly available for prophylactic use, public health efforts will be necessary to educate MSM and other high-risk populations about personal risk assessment and the role of PrEP in their HIV-preventive strategy. Because HIV transmission occurs through a variety of behavioral practices, population-specific public health campaigns have shown effectiveness in raising the awareness of each at-risk group. 22 The present study exposes a potential lack of accurate personal risk assessment in a sample of men who are members of a key population in which PrEP use should be targeted. Many factors may affect this disconnect between risk-takers and preventive interventions for which they may qualify. These may include the lack of public education about specific risk factors, social normalization of certain risk factors, personal denial of risk, lack of knowledge about PrEP, concern about potential side effects of the medications, and stigma associated with taking prophylactic medication. It was not within the scope of this study to elucidate the causal factors of this observation; it is our hope that future studies will explore this question. While most of the participants in this study did not feel their personal risk was great enough to use PrEP, it is important to note that, consistent with previous studies, 23 the participants who self-assessed as being sufficiently at-risk for HIV to warrant PrEP did meet the iPrEX eligibility criteria. Given this high concordance rate, it is important for health care providers to act on such patient perceptions appropriately. This may include offering HIV and STI testing, preventive counseling, post-exposure prophylaxis education, and potentially PrEP.
We found no significant association between having a primary care provider (PCP) and perceiving oneself as a potential PrEP user based on personal risk. This was also observed in the cases in which participants indicated their PCP was aware of their same-sex behaviors. Previous data suggest that disclosure of same-sex behaviors to a primary care provider improves communication and patient knowledge of MSM-targeted preventive HIV care and interventions. 24, 25 One would, therefore, expect that disclosed MSM under the care of a PCP would be more connected to their personal risk and the interventions for which they may qualify based on such risk, such as PrEP. The lack of such a connection suggested in this study may indicate that the PCPs of some of these at-risk men may not yet be adequately versed in the use of PrEP. PCPs may also have personal reservations about this intervention as well as differences of opinion concerning when it is indicated, further complicating patient education on this topic and potentially influencing patient self-perception of risk and need for PrEP. In either case, primary care visits are a potential area in which to improve accuracy of risk perception and to educate patients about potential preventive interventions. Further research is needed to better understand the implementation of PrEP in the primary care settings and to establish consensus guidelines for its use. This study has several limitations. Most significantly, participants were all MSM who either patronized commercial sex venues and/or were amenable to testing at these venues.
These clients each self-referred for HIV testing, demonstrating their pre-study desire to know their HIV status. This sample may not be representative of all men attending CSV nor the larger population of MSM. Testing took place in New York City, a unique metropolitan area that is not necessarily indicative of other cities or rural areas. Additionally, the specific demographics of the participants in this study may limit the extent to which the study can be applied to other populations. Possible social bias existed in the testing methods themselves. Since the surveys were interviewer administered, clients may have given answers they viewed as socially desirable. Interviewers reminded patients that the survey portion of their visit was anonymous in an attempt to mitigate this potential bias. The study is also limited by the use of iPrEX entry criteria as a gauge of whether a participant qualified for PrEP. Given the current absence of consensus guidelines for PrEP, the iPrEX study's entry criteria were used as a tool to roughly assess the risk of the sample studied. Although limited by several factors, the present observational study highlights lack of self-perceived HIV risk as a potential barrier to receiving available HIV prophylaxis in MSM. With limited self-perception of candidacy for interventions like PrEP, and the barriers that exist in the interaction between MSM patients and providers, interventions should be considered to better educate both physicians and patients about HIV risk mitigation.
